PTM Bio is using cutting-edge proteomics technology to examine profiles of proteins, histone epigenetic marks, and protein post-translational modifications. We integrate patient-derived proteomics information with genomics and transcriptomics data to identify biomarkers that can be used in IVD and drug sensitivity. Through discovery of therapeutic targets, identification of predictive biomarkers, and biomarker-guided drug discovery, we aim to make precision medicine a reality.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth?
YesIncluded in the Export Interest Directory?
YesBusiness Needs:
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements, Service (Maintenance, Training, Logistics, etc.)Products to be exported:
Custom antibody generation
End-to-end MS-based proteomic services 
Analysis of protein post translational modificationsCountries of Interest
1. All Countries listed below